CVE-2026-24222
NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected content that causes the agent to read and exfiltrate host environment…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.40%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected content that causes the agent to read and exfiltrate host environment variables not properly restricted during sandbox creation. A successful exploit of this vulnerability might lead to information disclosure.
- CVSS 3.1
- 8.6 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
- EPSS
- 0.40% probability · 33th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-497
- Affected
- nvidia/nemoclaw
- Source
- psirt@nvidia.com
References
- https://nvd.nist.gov/vuln/detail/CVE-2026-24222US Government Resource
- https://nvidia.custhelp.com/app/answers/detail/a_id/5837Vendor Advisory
- https://www.cve.org/CVERecord?id=CVE-2026-24222Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.